Trial Profile
Phase II clinical trial of tranexamic acid (LB 1148) to treat organ dysfunction associated with high-risk cardiovascular surgery
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 01 Mar 2022
Price :
$35
*
At a glance
- Drugs Tranexamic acid (Primary)
- Indications Multiple organ failure; Postoperative complications
- Focus Therapeutic Use
- Sponsors Leading BioSciences; Palisade Bio
- 04 Feb 2015 New trial record